New Key Statistics Module, Z-Score and F-Score
STU:MED Key Ratios
Market Cap € M | 137.75 |
Enterprise Value € M | 502.29 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 0.71 |
Price/Sales | 0.19 |
Price/Free Cash Flow | 3.44 |
Price/Owner Earnings | 5.42 |
Payout Ratio % | -- |
Revenue (TTM) € M | 730.00 |
EPS (TTM) € | -0.23 |
Beneish M-Score | -3.08 |
10-y EBITDA Growth Rate % | 16.40 |
5-y EBITDA Growth Rate % | 15.30 |
y-y EBITDA Growth Rate % | 10.30 |
EV-to-EBIT | 32.92 |
EV-to-EBITDA | 4.96 |
PEG | -- |
Shares Outstanding M | 47.50 |
Net Margin (%) | -1.48 |
Operating Margin % | 8.53 |
Pre-tax Margin (%) | -1.19 |
Quick Ratio | 1.71 |
Current Ratio | 1.75 |
ROA % (ttm) | -1.19 |
ROE % (ttm) | -5.14 |
ROIC % (ttm) | 10.48 |
Dividend Yield % | -- |
Altman Z-Score | 1.16 |
STU:MED Number of Guru Trades
STU:MED Volume of Guru Trades
Gurus Latest Trades with STU:MED
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
STU:MED is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data